Heart failure guidelines implementation: Lifting barriers using registries and networks

由 Keramida, Kalliopi, Filippatos, Gerasimos
發表在 Anatol J Cardiol (2020)

Clinical development plan for regenerative therapy in heart failure

由 Terzic, Andre, Behfar, Atta, Filippatos, Gerasimos
發表在 Eur J Heart Fail (2016)

Cardio‐oncology services during the COVID‐19 pandemic: practical considerations and challenges

由 Farmakis, Dimitrios, Keramida, Kalliopi, Filippatos, Gerasimos
發表在 Eur J Heart Fail (2020)

Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice

由 Filippatos, Gerasimos, Farmakis, Dimitrios, Parissis, John, Lekakis, John
發表在 BMC Med (2015)

Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice

由 Butler, Javed, Zannad, Faiez, Filippatos, Gerasimos, Anker, Stefan D., Packer, Milton
發表在 Eur Heart J (2020)

Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies

由 Anker, Stefan D., Ponikowski, Piotr, Mitrovic, Veselin, Peacock, W. Frank, Filippatos, Gerasimos
發表在 Eur Heart J (2015)

Pulmonary Oedema—Therapeutic Targets

由 Chioncel, Ovidiu, Collins, Sean P, Ambrosy, Andrew P, Gheorghiade, Mihai, Filippatos, Gerasimos
發表在 Card Fail Rev (2015)

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function

由 Tschöpe, Carsten, Butler, Javed, Farmakis, Dimitrios, Morley, Deborah, Rao, Ishu, Filippatos, Gerasimos
發表在 ESC Heart Fail (2020)

Fas induces apoptosis in human coronary artery endothelial cells in vitro

由 Filippatos, Gerasimos, Ang, Edmund, Gidea, Claudia, Dincer, Erhan, Wang, Rongqi, Uhal, Bruce D
出版 2004

Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study

由 Campbell, Ruth C., Sui, Xuemei, Filippatos, Gerasimos, Love, Thomas E., Wahle, Christy, Sanders, Paul W., Ahmed, Ali
出版 2009

Telephone based survey in adults with congenital heart disease during COVID-19 pandemic

由 Frogoudaki, Alexandra A., Farmakis, Dimitrios, Tsounis, Dimitrios, Liori, Sotiria, Stamoulis, Konstadinos, Ikonomidis, Ignatios, Filippatos, Gerasimos, Parissis, John
發表在 Cardiol J (2020)

Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure

由 Parissis, John T., Nikolaou, Maria, Farmakis, Dimitrios, Paraskevaidis, Ioannis A., Bistola, Vassiliki, Venetsanou, Koula, Katsaras, Dimitrios, Filippatos, Gerasimos, Kremastinos, Dimitrios T.
出版 2009

Global Longitudinal Strain of the Systemic Ventricle Is Correlated with Plasma Galectin-3 and Predicts Major Cardiovascular Events in Adult Patients with Congenital Heart Disease

由 Frogoudaki, Alexandra A., Pantelakis, Ioannis, Bistola, Vasiliki, Kroupis, Christos, Birba, Dionysia, Ikonomidis, Ignatios, Alexopoulos, Dimitrios, Filippatos, Gerasimos, Parissis, John
發表在 Medicina (Kaunas) (2020)

Effect of Serum Insulin on the Association between Hyperuricemia and Incident Heart Failure

由 Desai, Ravi V., Ahmed, Mustafa I., Fonarow, Gregg C., Filippatos, Gerasimos S., White, Michel, Aban, Inmaculada B., Aronow, Wilbert S., Ahmed, Ali
出版 2010

Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry

由 Cowie, Martin R., Schöpe, Jakob, Wagenpfeil, Stefan, Tavazzi, Luigi, Böhm, Michael, Ponikowski, Piotr, Anker, Stefan D., Filippatos, Gerasimos S., Komajda, Michel
發表在 ESC Heart Fail (2021)

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney dise...

由 Pitt, Bertram, Kober, Lars, Ponikowski, Piotr, Gheorghiade, Mihai, Filippatos, Gerasimos, Krum, Henry, Nowack, Christina, Kolkhof, Peter, Kim, So-Young, Zannad, Faiez
出版 2013

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE†

由 Mebazaa, Alexandre, Nieminen, Markku S., Filippatos, Gerasimos S., Cleland, John G., Salon, Jeffrey E., Thakkar, Roopal, Padley, Robert J., Huang, Bidan, Cohen-Solal, Alain
出版 2009

Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses

由 Marvaki, Apostolia, Kolovou, Vana, Katsiki, Niki, Boutsikou, Maria, Kotanidou, Anastasia, Orfanos, Stylianos, Filippatos, Gerasimos, Marvaki, Katerina, Koumoulidis, Anastasios, Mavrogeni, Sophie, Kolovou, Genovefa
出版 2014

Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular‐only pacing

由 Filippatos, Gerasimos, Birnie, David, Gold, Michael R., Gerritse, Bart, Hersi, Ahmad, Jacobs, Sandra, Kusano, Kengo, Leclercq, Christophe, Mullens, Wilfried, Wilkoff, Bruce L.
發表在 Eur J Heart Fail (2017)

Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy

由 Okonko, Darlington O., Jouhra, Fadi, Abu‐Own, Huda, Filippatos, Gerasimos, Colet, Josep Comin, Suki, Chainey, Mori, Claudio, Ponikowski, Piotr, Anker, Stefan D.
發表在 ESC Heart Fail (2019)